New Centre supports Nano Flow Cytometry Investigations

A new facility to support existing and potential users of its Nano-Flow Cytometry platform, has been established by NanoFCM Co Ltd. Located in Nottingham’s biotech incubator Medicity, the new centre will allow a close interaction with the European scientific community, as well as participation in joint research projects or consortia.

The fully functioning lab equipped with two NanoAnalyzer* N30 instruments allows measurement of biological and synthetic substrates, such as extracellular vesicles, nanoparticle carriers, mitochondria and gold nanoparticles. The Centre of Excellence is led by Dr Ben Peacock, Application Scientist, whose research at Sheffield University has focused on exosomes. The facility also incorporates a sales office serving Europe, MiddleEast and Africa Region.

Parent company NanoFCM Inc headquartered in Xiamen, Fujian province, China, developed nano-flow cytometry out of Professor Xiaomei Yan’s work at Xiamen University. This technology has the ability to perform multiple parameter analysis on sub-micron particles, which are typically too small to be detected by conventional and micro flow cytometry. "NanoFCM has focused on the Chinese market during its first 4 years of existence and it has been very successful with the nano-bio research community. We felt this year was the right time to expand internationally, starting with Europe and shortly afterwards in North America. This network of support and sales offices will allow to sustain a global user base" said Dr Shaobin Zhu, CEO of NanoFCM Inc.

"Technological advances provided by NanoFCM’s NanoAnalyzer platform will turbocharge research on the biological functions of extracellular vesicles and their use as diagnostic and therapeutic tools for diseases" said Dimitri Aubert, Managing Director and Global Vice President for Sales and Marketing "In addition to the field of EVs, NanoFCM also aims to bring significant analytical capability improvements to gene therapy, vaccines and drug delivery research areas, all being widely represented in Europe.”

*The NanoAnalyzer is designed For Research Use Only. It is not for use in diagnostic procedures